DUL.F
Alnylam Pharmaceuticals, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
202.30
▲ 5.95 (3.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
195.80
Prev close
196.35
Day high
203.30
Day low
195.55
Volume
50
Market cap
$27.07B
P/E (TTM)
41.12
52W range
173.50 – 423.00
Day trading desk
Gap from prior close
-0.28%
Prior close 196.35
VWAP
202.30
0.00% from price
Relative volume
0.98×
Normal
Session range
3.96%
195.55 – 203.30
Position in range
87%
Near session high
ATR (14D)
6.70
3.31% of price
Prior day high
207.40
PDH
Prior day low
196.35
PDL
Bid / ask spread
—
Quote not published
Session volume
50
Avg 51
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.79%
+4.2%
1M
-14.24%
-18.0%
3M
-19.98%
-23.1%
6M
-26.91%
-38.0%
YTD
-40.13%
-52.4%
1Y
-49.51%
-69.5%
3Y
+14.94%
-59.2%
5Y
+26.28%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DUL.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
246.21K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 1, 26 | PYOTT DAVID E I Director |
— | 3.83K | — | Direct |
| Jun 1, 26 | PYOTT DAVID E I Director |
SELL | 3.83K | $1.15M | Direct |
| May 20, 26 | SIGAL CHARLES ELLIOTT Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | PYOTT DAVID E I Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | KELLOGG PETER N Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | HAMBURG MARGARET A Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | AUSIELLO DENNIS A Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | SCHULMAN AMY W. Director |
STOCK | 838 | $0 | Direct |
| May 20, 26 | REITAN COLLEEN F. Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | BRANDICOURT OLIVIER Director |
STOCK | 671 | $0 | Direct |
| May 20, 26 | ARBUCKLE STUART A Director |
STOCK | 671 | $0 | Direct |
| May 13, 26 | SCHULMAN AMY W. Director |
CONVERSION | 11.25K | $789.75K | Direct |
| Apr 6, 26 | MCLAUGHLIN MELISSA Officer |
SELL | 3.91K | $1.27M | Direct |
| Mar 5, 26 | FITZGERALD KEVIN JOSEPH Officer |
SELL | 1.29K | $417.69K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BONNEY MICHAEL W |
Director | 20.80K | Conversion of Exercise of derivative security |
FITZGERALD KEVIN JOSEPH |
Officer | 21.11K | Sale |
GARG PUSHKAL |
Officer | 19.37K | Sale |
GREENSTREET YVONNE L |
Chief Executive Officer | 96.10K | Sale |
POULTON JEFFREY V |
Chief Financial Officer | 61.86K | Sale |
PYOTT DAVID E I |
Director | 29.48K | Conversion of Exercise of derivative security |
SCHULMAN AMY W. |
Director | 24.05K | Stock Award(Grant) |
SHARP PHILLIP A |
Director | 266.90K | Conversion of Exercise of derivative security |
SUPRAN BRYAN |
Officer | 14.56K | Stock Award(Grant) |
TANGULER TOLGA |
Officer | 34.30K | Sale |
Fundamentals
Market cap$27.07B
Enterprise value$26.75B
Revenue (TTM)$4.80B
Gross profit$3.83B
EBITDA$1.05B
Net income$774.71M
EPS (TTM)$4.92
Free cash flow$271.54M
Total cash$3.31B
Total debt$2.99B
Book value / share$8.66
Shares outstanding133.81M
Float133.24M
Short % of float—
Dividend yield—
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E41.12
Forward P/E-53.80
PEG ratio0.45
Price / sales—
Price / book23.35
EV / revenue5.57
EV / EBITDA25.37
Gross margin79.65%
Operating margin17.93%
Profit margin16.13%
Return on equity96.56%
Return on assets12.34%
Debt / equity220.62
Current ratio3.06
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.71B | $2.25B | $1.83B | $1.04B | +65.2% |
| Operating revenue | $3.71B | $2.25B | $1.83B | $1.04B | +65.2% |
| Cost of revenue | $681.87M | $323.37M | $310.41M | $168.82M | +110.9% |
| Gross profit | $3.03B | $1.92B | $1.52B | $868.60M | +57.5% |
| Research & development | $1.32B | $1.13B | $1.00B | $883.01M | +17.2% |
| Selling, general & admin | $1.21B | $975.53M | $795.65M | $770.66M | +24.1% |
| Total operating expense | $2.53B | $2.10B | $1.80B | $1.65B | +20.4% |
| Operating income | $501.58M | -$176.88M | -$282.18M | -$785.07M | +383.6% |
| Net interest income | -$141.16M | -$19.87M | -$25.66M | -$131.16M | -610.5% |
| Pre-tax income | $323.15M | -$377.38M | -$433.52M | -$1.13B | +185.6% |
| Tax provision | $9.40M | -$99.22M | $6.72M | $4.16M | +109.5% |
| Net income | $313.75M | -$278.16M | -$440.24M | -$1.13B | +212.8% |
| Net income to common | $313.75M | -$278.16M | -$440.24M | -$1.13B | +212.8% |
| Basic EPS | 2.39 | -2.18 | -3.52 | -9.30 | +209.6% |
| Diluted EPS | 2.33 | -2.18 | -3.52 | -9.30 | +206.9% |
| EBIT | $575.78M | -$235.52M | -$312.30M | -$971.02M | +344.5% |
| EBITDA | $631.44M | -$178.85M | -$258.24M | -$926.56M | +453.1% |
| Basic shares | 131.00M | 127.65M | 124.91M | 121.69M | +2.6% |
| Diluted shares | 134.68M | 127.65M | 124.91M | 121.69M | +5.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.66B | $966.43M | $812.69M | $866.39M | +71.5% |
| Cash & short-term investments | $2.91B | $2.69B | $2.44B | $2.19B | +7.9% |
| Accounts receivable | $777.57M | $405.31M | $327.79M | $237.96M | +91.8% |
| Inventory | $82.72M | $78.51M | $89.15M | $128.96M | +5.4% |
| Total current assets | $4.05B | $3.30B | $2.98B | $2.69B | +22.9% |
| Property, plant & equipment | $708.06M | $693.93M | $725.79M | $738.63M | +2.0% |
| Total assets | $4.97B | $4.24B | $3.83B | $3.55B | +17.1% |
| Total current liabilities | $1.47B | $1.19B | $967.79M | $767.91M | +23.6% |
| Long-term debt | $1.01B | $1.02B | $1.02B | $1.02B | -1.6% |
| Total debt | $1.28B | $1.30B | $1.31B | $1.32B | -1.4% |
| Total liabilities | $4.18B | $4.17B | $4.05B | $3.70B | +0.1% |
| Retained earnings | -$6.70B | -$7.29B | -$7.01B | -$6.57B | +8.0% |
| Shareholder equity | $789.18M | $67.09M | -$220.64M | -$158.22M | +1,076.3% |
| Working capital | $2.58B | $2.11B | $2.01B | $1.92B | +22.5% |
| Net tangible assets | $789.18M | $67.09M | -$220.64M | -$158.22M | +1,076.3% |
| Shares issued | 132.38M | 129.29M | 125.79M | 123.92M | +2.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $313.75M | -$278.16M | -$440.24M | -$1.13B | +212.8% |
| Depreciation & amortisation | $55.66M | $56.67M | $54.05M | $44.47M | -1.8% |
| Stock-based compensation | $348.24M | $272.08M | $221.68M | $230.65M | +28.0% |
| Change in working capital | -$444.78M | -$214.08M | $57.26M | $7.62M | -107.8% |
| Operating cash flow | $524.08M | -$8.31M | $104.16M | -$541.27M | +6,405.1% |
| Capital expenditure | -$58.70M | -$34.28M | -$62.21M | -$72.06M | -71.2% |
| Investing cash flow | $436.33M | -$116.84M | -$336.35M | $169.35M | +473.4% |
| Financing cash flow | -$305.19M | $294.16M | $172.13M | $425.75M | -203.8% |
| Free cash flow | $465.38M | -$42.59M | $41.95M | -$613.33M | +1,192.7% |
| End cash position | $1.66B | $968.65M | $814.88M | $868.56M | +71.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.29B | $1.17B | $1.10B | $1.25B | $773.69M | — | +10.6% |
| Operating revenue | $1.29B | $1.17B | $1.10B | $1.25B | $773.69M | — | +10.6% |
| Cost of revenue | $298.45M | $211.12M | $267.72M | $200.15M | $142.95M | — | +41.4% |
| Gross profit | $992.50M | $956.05M | $829.31M | $1.05B | $630.74M | — | +3.8% |
| Research & development | $413.13M | $364.87M | $372.22M | $358.81M | $323.62M | — | +13.2% |
| Selling, general & admin | $347.92M | $322.55M | $325.37M | $322.08M | $323.31M | — | +7.9% |
| Total operating expense | $761.06M | $687.42M | $697.59M | $680.89M | $646.93M | — | +10.7% |
| Operating income | $231.44M | $268.64M | $131.72M | $367.98M | -$16.20M | — | -13.8% |
| Net interest income | -$53.91M | -$42.69M | -$102.71M | -$15.72M | -$33.97M | — | -26.3% |
| Pre-tax income | $177.81M | $221.65M | $161.14M | $238.97M | -$41.31M | — | -19.8% |
| Tax provision | $13.31M | $15.66M | -$25.28M | -$12.12M | $30.92M | — | -15.0% |
| Net income | $164.49M | $205.99M | $186.42M | $251.08M | -$72.23M | — | -20.1% |
| Net income to common | $164.49M | $205.99M | $186.42M | $251.08M | -$72.23M | — | -20.1% |
| Basic EPS | 1.23 | 1.55 | 0.84 | — | -0.55 | -0.14 | -20.6% |
| Diluted EPS | 1.21 | 1.51 | 0.82 | — | -0.55 | -0.14 | -19.9% |
| EBIT | $259.86M | $290.94M | $290.47M | $283.37M | $20.15M | — | -10.7% |
| EBITDA | $273.76M | $304.49M | $303.98M | $297.17M | $34.09M | — | -10.1% |
| Basic shares | 133.61M | 132.89M | 132.23M | — | — | 129.68M | +0.5% |
| Diluted shares | 138.28M | 138.23M | 136.28M | — | — | 129.68M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.71B | $1.71B | $1.66B | $1.49B | $1.11B | -0.1% |
| Cash & short-term investments | $3.31B | $3.01B | $2.91B | $2.72B | $2.86B | +9.9% |
| Accounts receivable | $912.74M | $883.96M | $777.57M | $964.77M | $567.11M | +3.3% |
| Inventory | $97.11M | $84.03M | $82.72M | $75.38M | $71.69M | +15.6% |
| Total current assets | $4.62B | $4.22B | $4.05B | $3.95B | $3.64B | +9.5% |
| Property, plant & equipment | $737.50M | $707.56M | $708.06M | $693.14M | $692.19M | +4.2% |
| Total assets | $5.56B | $5.13B | $4.97B | $4.85B | $4.57B | +8.4% |
| Total current liabilities | $1.51B | $1.35B | $1.47B | $1.56B | $1.30B | +12.1% |
| Long-term debt | $1.01B | $1.01B | $1.01B | $1.04B | $1.03B | +0.2% |
| Total debt | $1.27B | $1.27B | $1.28B | $1.31B | $1.30B | -0.4% |
| Total liabilities | $4.20B | $4.05B | $4.18B | $4.62B | $4.32B | +3.7% |
| Retained earnings | -$6.33B | -$6.50B | -$6.70B | -$7.16B | -$7.41B | +2.5% |
| Shareholder equity | $1.35B | $1.08B | $789.18M | $233.89M | $250.59M | +25.9% |
| Working capital | $3.11B | $2.87B | $2.58B | $2.40B | $2.34B | +8.3% |
| Net tangible assets | $1.35B | $1.08B | $789.18M | $233.89M | $250.59M | +25.9% |
| Shares issued | 133.73M | 133.44M | 132.38M | 131.79M | 130.98M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $164.49M | $205.99M | $186.42M | $217.81M | -$72.23M | -20.1% |
| Depreciation & amortisation | $13.90M | $13.55M | $13.51M | $13.80M | $13.94M | +2.6% |
| Stock-based compensation | $86.63M | $70.15M | $71.63M | $108.21M | $111.68M | +23.5% |
| Change in working capital | -$28.27M | -$297.73M | -$73.15M | -$178.74M | $26.15M | +90.5% |
| Operating cash flow | $326.72M | $70.50M | $163.56M | $351.03M | $129.81M | +363.4% |
| Capital expenditure | -$34.68M | -$21.83M | -$23.29M | -$12.14M | -$14.29M | -58.8% |
| Investing cash flow | -$363.46M | -$25.54M | -$37.17M | $501.11M | -$141.38M | -1,323.0% |
| Financing cash flow | $36.24M | $15.71M | $45.32M | -$474.27M | $77.68M | +130.6% |
| Free cash flow | $292.04M | $48.67M | $140.26M | $338.89M | $115.51M | +500.0% |
| End cash position | $1.71B | $1.71B | $1.66B | $1.49B | $1.12B | -0.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.44B | +15.3% |
| Next quarter | — | — | $1.58B | +43.8% |
| Current year | — | — | $5.49B | +47.8% |
| Next year | — | — | $6.94B | +26.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.18%
Held by institutions101.71%
Institutions holding1.19K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
196.14
+3.14% from price
SMA 20
200.77
+0.76% from price
SMA 50
232.43
-12.96% from price
SMA 100
246.12
-17.80% from price
SMA 200
282.89
-28.49% from price
EMA 12
199.49
+1.41% from price
EMA 26
209.49
-3.43% from price
EMA 50
224.04
-9.71% from price
RSI (14)
45.4
Neutral
MACD (12,26,9)
-10.00
Hist 2.92
ATR (14)
6.70
3.31% of price
Realised vol 30D
108.3%
Annualised
Bollinger upper
243.89
20, 2σ
Bollinger lower
157.65
20, 2σ
50 / 200 cross
Death
232.43 vs 282.89
Trend bias
Below 200
-28.49%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.27
Less volatile than market
Correlation to SPY
-0.08
Largely independent
Realised vol 30D
108.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-58.0%
Peak to trough
Max drawdown 5Y
-58.0%
Peak to trough
ATR 14
6.70
3.31% of price
Beta (reported)
0.28
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 26 | BMO Capital | INITIATED | Outperform | Outperform |
| Aug 14, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 4, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 4, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Raymond James | UPGRADE | Outperform | Strong Buy |
| Aug 3, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
Headlines
Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?
Insider Monkey · 7m ago
Dow Jones Futures: Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 10m ago
An $808 monthly payment is reshaping who can afford a new car
TheStreet · 16m ago
UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them.
Motley Fool · 19m ago
Treasury Market Still Functioning, Fed's Kashkari Says
Bloomberg · 20m ago
Former cricket captains appeal to Pakistan over Khan health care
AFP · 21m ago
3 Growth Stocks That Could Skyrocket in the Second Half of 2026
Motley Fool · 21m ago
Nvidia Notifies Customers About AI-Related Price Hikes
Bloomberg · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.